[HTML][HTML] Anticoagulation and amiodarone for new atrial fibrillation after coronary artery bypass grafting: prescription patterns and 30-day outcomes in the United States …
JD Matos, S McIlvaine, M Grau-Sepulveda… - The Journal of thoracic …, 2021 - Elsevier
Objective We sought to elucidate national practice patterns regarding anticoagulation and
antiarrhythmic medication use at discharge and examine short-term patient outcomes …
antiarrhythmic medication use at discharge and examine short-term patient outcomes …
Delivery of drugs, growth factors, genes and stem cells via intrapericardial, epicardial and intramyocardial routes for sustained local targeted therapy of myocardial …
M Maslov, S Foianini, M Lovich - Expert Opinion on Drug Delivery, 2017 - Taylor & Francis
Introduction: Local myocardial delivery (LMD) of therapeutic agents is a promising strategy
that aims to treat various myocardial pathologies. It is designed to deliver agents directly to …
that aims to treat various myocardial pathologies. It is designed to deliver agents directly to …
Acute care and secondary prevention of stroke with newly detected versus known atrial fibrillation
R Wang, K Macha, D Haupenthal… - European Journal of …, 2022 - Wiley Online Library
Background and purpose Atrial fibrillation (AF) in stroke patients can be classified as either
“known AF”(KAF), defined as AF confirmed before stroke onset, or “AF detected after …
“known AF”(KAF), defined as AF confirmed before stroke onset, or “AF detected after …
Impact of amiodarone use on metoprolol concentrations, α‐OH‐metoprolol concentrations, metoprolol dosing and heart rate: A cross‐sectional study
S Robert, MO Pilon, E Oussaïd… - Pharmacology …, 2023 - Wiley Online Library
Small studies suggest that amiodarone is a weak inhibitor of cytochrome P450 (CYP) 2D6.
Inhibition of CYP2D6 leads to increases in concentrations of drugs metabolized by the …
Inhibition of CYP2D6 leads to increases in concentrations of drugs metabolized by the …
Digoxin and amiodarone on the risk of ischemic stroke in atrial fibrillation: an observational study
Purpose: The present study compared the risk of ischemic stroke in atrial fibrillation (AF)
patients receiving digoxin and amiodarone. Methods: A retrospective cohort study was …
patients receiving digoxin and amiodarone. Methods: A retrospective cohort study was …
Methods for treating atrial fibrillation
PG Milner, DJ Ellis - US Patent 9,549,912, 2017 - Google Patents
A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, eg
fungichromin having five-membered rings with one oxygen as the only ring hetero atom, eg …
fungichromin having five-membered rings with one oxygen as the only ring hetero atom, eg …
Protective Effects of Intravenous Magnesium Sulfate in Stroke Patients Receiving Amiodarone: A Randomized Controlled Trial
Y Panahi, M Mojtahedzadeh, A Najafi, M Gheini… - … Properties of Plant …, 2021 - Springer
Anti-arrhythmic agents, like amiodarone, interfere at different stages of the ischemic stroke.
However, amiodarone was accompanied with immunological pulmonary complications and …
However, amiodarone was accompanied with immunological pulmonary complications and …
Povezanost mitralne regurgitacije s trombom u lijevom atriju bolesnika s fibrilacijom atrija
I Ivanac Vranešić - 2023 - repozitorij.unizg.hr
Sažetak Uvod i ciljevi rada: Fibrilacija atrija (FA) je najčešća postojana srčana aritmija koja
značajno povećava rizik od nastanka tromba u lijevom atriju (LAT). Dosadašnje studije o …
značajno povećava rizik od nastanka tromba u lijevom atriju (LAT). Dosadašnje studije o …
心房顫動病人之心律控制藥物治療與中風風險之探討
王昱文 - 國立臺灣大學臨床藥學研究所學位論文, 2016 - airitilibrary.com
研究背景: 心房顫動是造成缺血性中風的一個顯著危險因子, 而心律控制(rhythm control)
藥物可以改善心房顫動病人的症狀, 然而過去針對心律控制藥物的研究多為比較其矯正心律的 …
藥物可以改善心房顫動病人的症狀, 然而過去針對心律控制藥物的研究多為比較其矯正心律的 …
Антитромботическая терапия у гериатрических пациентов с неклапанной фибрилляцией предсердий
LM Ena, VO Artemenko… - Журнал Неврології ім …, 2018 - neuroscience.com.ua
Анотація У статті наведено загальні підходи проведення антитромботичної терапії, її
тривалості, контролю лікування, оцінки побічних ефектів, показань для …
тривалості, контролю лікування, оцінки побічних ефектів, показань для …